Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Ecke TH, Voß PC, Schlomm T, Rabien A, Friedersdorff F, Barski D, Otto T, Waldner M, Veltrup E, Linden F, Hake R, Eidt S, Roggisch J, Heidenreich A, Rieger C, Kastner L, Hallmann S, Koch S, Wirtz RM.
Ecke TH, et al. Among authors: rieger c.
Int J Mol Sci. 2022 Jul 18;23(14):7898. doi: 10.3390/ijms23147898.
Int J Mol Sci. 2022.
PMID: 35887247
Free PMC article.